PROVECTUS BIOPHARMACEUTICALS, INC. Adjustments to Additional Paid in Capital, Other
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) reported Adjustments to Additional Paid in Capital, Other of $315.10 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2025-05-14
- PROVECTUS BIOPHARMACEUTICALS, INC. adjustments to additional paid in capital, other for the quarter ending 2025-03-31 was $315.10K.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month |
|---|---|
| 2025-03-31 | $315.10K 10-Q · filed 2025-05-14 |